Sept 26, 2020 – Rachael Durie, PharmD at AltaThera presented new data on AFIB dosing to the Alliance of Cardiovascular Professionals. She highlights the clinical benefits of reduced length of hospital stay, especially relevant during COVID. In addition, she explains the hospital cost savings with the 1-day regimen recently approved by FDA.